MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: BioNTech Cell & Gene Therapies GmbH

Raw xml | Download


<Organization xmlns="http://hl7.org/fhir">
  <id value="mii-exa-mtb-study-sponsor-biontech"/>
  <language value="de"/>
  <text>
    <status value="generated"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: Organization mii-exa-mtb-study-sponsor-biontech</b></p><a name="de-mii-exa-mtb-study-sponsor-biontech"> </a><a name="de-hcmii-exa-mtb-study-sponsor-biontech"> </a><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/organization-type crs}">Clinical Research Sponsor</span></p><p><b>name</b>: BioNTech Cell &amp; Gene Therapies GmbH</p></div>
  </text>
  <type>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/organization-type"/>
      <code value="crs"/>
      <display value="Clinical Research Sponsor"/>
    </coding>
  </type>
  <name value="BioNTech Cell &amp; Gene Therapies GmbH"/>
</Organization>